Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,845 | 24,179 | 14,200 | 16,105 | 14,736 |
| Marketable Securities | 46,253 | 41,190 | 13,607 | 19,221 | 12,386 |
| TOTAL | $62,121 | $67,233 | $29,090 | $36,763 | $28,576 |
| Non-Current Assets | |||||
| PPE Net | 2,460 | 2,544 | 2,919 | 2,997 | 2,655 |
| Intangibles | 2,445 | 2,577 | 2,672 | 2,641 | 2,738 |
| TOTAL | $4,905 | $5,121 | $5,591 | $5,638 | $5,393 |
| Total Assets | $67,026 | $72,354 | $34,681 | $42,401 | $33,969 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 579 | 786 | 657 | 757 | 688 |
| Accrued Expenses | 1,957 | 1,897 | 1,553 | 2,428 | 2,389 |
| TOTAL | $7,050 | $7,197 | $6,724 | $7,806 | $4,698 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,514 | 4,514 | 4,514 | 4,621 | 1,621 |
| TOTAL | $13,472 | $14,601 | $15,729 | $16,778 | $5,683 |
| Total Liabilities | $20,522 | $21,798 | $22,453 | $24,584 | $10,381 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,184 | 26,151 | 19,249 | 19,236 | 19,147 |
| Common Shares | 262 | 262 | 193 | 193 | 191 |
| Retained earnings | -114,377 | -110,098 | -104,807 | -99,096 | -92,184 |
| Other shareholders' equity | -572 | -852 | -1,383 | -1,695 | -1,968 |
| TOTAL | $46,504 | $50,556 | $12,228 | $17,817 | $23,588 |
| Total Liabilities And Equity | $67,026 | $72,354 | $34,681 | $42,401 | $33,969 |